Abstract Removing the spleen prior to ischemic stroke abrogates immunologic response to brain injury and reduces cerebral infarction. However, the effectiveness of splenectomy for neuroprotection after stroke has not been established. Moreover, the risks of the surgical splenectomy in stroke patients create a major obstacle to removing the spleen's inflammatory response. We hypothesized that acute splenic irradiation will ablate splenic cells and thereby will diminish stroke progression. Male adult Sprague Dawley rats were subjected to 2-h middle cerebral artery occlusion, then CT-scanned for spleen localization, and irradiated to the lateral splenic region with 8 Gy of Cobalt-60 at 3, 4, 6, or 8 h after start of cerebral ischemia. Untreated controls underwent the same procedures except that sham irradiation was applied. At 2 or 7 days after ischemia, the rats were euthanized, and the brains, recovered for the assessment of brain injury and the extent of neuroinflammation. Irradiation at 3 h reduced spleen weight and lymphocyte blood levels after stroke. Splenic irradiation at 3 and 4 h after start of ischemia significantly reduced cerebral infarction volumes measured at 48 h and 7 days, respectively. The histological analysis on day 7 revealed reduced counts of microglia, infiltrating T cells, and apoptotic neurons in the rats irradiated at 4 h. The noninvasive single-dose procedure of splenic irradiation performed within a time interval of up to 4 h offers neuroprotection against ischemic stroke possibly by abrogating deployment of splenic cells to the brain.
Introduction
Recent studies reported that targeting spleen-derived inflammatory response to ischemic injury limited expansion of brain infarction and increased neuronal survival after stroke [1] . The spleen is a lymphoid organ containing the largest pool of immunological cells in the system [2] . Upon brain ischemia, the spleen is activated via neural sympathetic pathways and deploys immunologic cells to the sites of inflammation in cerebral tissues [1] . It has been demonstrated that removal of the spleen 2 weeks prior to permanent middle cerebral artery occlusion (MCAO) in the rat significantly reduced neurodegeneration when compared with untreated rats with brain ischemia. Preventive splenectomy also reduced levels of microglia, macrophages, and neutrophils in cerebral tissues [1] . We hypothesized that targeting spleen acutely after stroke will also diminish the progression of brain injury. However, the risks of surgical splenectomy would present a major obstacle to translating this method to clinical management of stroke. Thus, we proposed to explore and develop splenic irradiation in the animal model of ischemic stroke. We hypothesized that splenic irradiation applied at single low dose in the acute ischemic stroke will deplete splenic immunological cells that mediate neuroinflammation and thereby will reduce brain damage.
Methods

Experimental Design
Forty six adult male Sprague Dawley rats weighing 300-350 g underwent sham surgery or intraluminal 120-min MCAO and were allocated (according to the randomization table) to Cobalt-60 irradiation or the sham-irradiation groups. Irradiation was performed at 3 h (experiment 1) or 4, 6, and 8 h (experiment 2) after the start of ischemia. The experiments were done in a blinded fashion. All procedures involving animals complied with the NIH Guide for the Care and Use of Laboratory Animals and were approved by the Institutional Animal Care and Use Committee at the Loma Linda University. The rats in the experiment 1 underwent daily neurobehavioral assessment and collection of peripheral blood samples prior to euthanization at 48 h after MCAO to determine brain infarction size with 2,3,5-triphenyltetrazolium chloride (TTC) as described previously [3] . In experiment 2, rats were euthanized on day 7, when the brains, lungs, spleens, and visceral organs were collected for histology procedures. All euthanization procedures used ketamine/xylazine anesthesia (100/10 mg/kg, i.p.). Body weight, neurological scores, and mortality were recorded daily.
Animal Model of Focal Cerebral Ischemia
Focal cerebral ischemia was done with 4-0 filament occluding MCA for 120 min, as described [3] . During surgery, isoflurane anesthesia (4.5 % isoflurane for induction and 2 % for maintenance in 30 % oxygen/medical air) was administered via a nose cone. Every rat was tested for focal neurological deficits at 110 min after the beginning of occlusion. Exclusion criteria comprised lack of neurological deficit, signs of hemorrhage, and anesthesia or surgery failure. In total, five rats were excluded from the study based on these criteria.
CT Spleen Localization Procedure and Splenic Irradiation
Thirty minutes prior to irradiation, the animals were anesthetized with isoflurane (2-3 % for induction, 1-1.5 % maintenance) and immobilized in a custom-designed holder. Rats underwent a high resolution (512×512 image matrix, 0.625-mm slice thickness) CT scan (LightSpeed VCT, GE Healthcare Technologies, Waukesha, WI) and the center of the spleen was localized relative to a longitudinal reference scale (with millimeter gradation) and relative to the bottom of the holder in a vertical direction. The center of the left ear bar, with a known longitudinal distance to the zero-point of the longitudinal scale, served as visible landmarks in the CT scan. Subsequently, the rats were taken to the Co-60 irradiation unit (Eldorado Cobalt 60 Teletherapy Unit, Theratronics International Ltd., Ottawa, Canada). A 30×30-mm brass collimator, shielding the nontargeted tissues to better than 3 % of the primary dose, was positioned such that the center of the spleen, as determined on CT, coincided with the center of the collimator in a longitudinal direction. The vertical height of the collimator was adjusted using a set of 1-mm metal shim plates so that the vertebral column of the rats was shielded, yet more than 80 % of the spleen was covered by the primary radiation field. A dose of 8 Gy was delivered to the dose maximum, which was positioned at a depth of 2 mm, coinciding with the depth of the spleen, using an acrylic build-up plate of 3-mm thickness. The dose of 8 Gy was selected based on a series of pilot irradiations, showing that this dose was tolerated well by the rats, yet it provided a significant reduction of spleen size and weight. The length of the cobalt irradiation, performed at a source to axis distance of 800 mm, was adjusted according to the actual source activity and lasted for about 5 min. Untreated controls were exposed to the same CT scan, immobilized for the same length of time, and positioned on the Cobalt irradiator without turning it on (sham irradiation).
Neurological Assessment
Neurobehavioral evaluation utilized a modified Garcia scoring system that tested sensorimotor function and recorded gait abnormalities and beam walking distance [4] . Individual scores could sum up to a maximum of 24 points.
Blood Cell Counting
Blood cell counts (leukocytes, lymphocytes, monocytes/ macrophages, and granulocytes) were done with hematology analyzer using blood from animals' tail collected for heparin (HESKA Vet ABC-Diff Hematology Analyzer, Heska Corp., Waukesha, WI, USA) [5] .
Histological Analysis of Infarction Volume
The animals were euthanized on day 7 after ischemia and subjected to cardiac perfusion with ice cold 0.1 mol/L PBS followed by 10 % formalin. The brains were recovered and postfixed in formalin, then cryoprotected, frozen in liquid nitrogen, and cryosectioned into 10-μm slices. Ten samples in total were taken (in millimeter levels) at +2, +1, 0, −1, −2, −3, −4, −5, −6, and −7 with respect to bregma and stained for Nissl substance as described [6] , photographed under×1.25 magnification, and analyzed using the Adobe Photoshop 6.0 program (Adobe, San Jose, CA). Noninfarcted ipsilateral tissue value was subtracted from the contralateral hemisphere pixel measurement to obtain the infarction size corrected for edema. The infarct volume of all ten slices was summed up to obtain the infarction volume [3] .
Fluorescence Staining and Manual Cell Counting
Fluorescence staining was performed on four sections per brain from the central portion of the lesion as previously described [6] . The primary antibodies used were rabbit antiIba1 (Wako), mouse anti-T cell marker (Santa Cruz Biotechnology, Inc., Santa Cruz, CA), and mouse anti-NeuN (Millipore, Temecula, CA), each diluted 1:100. The respective secondary antibodies (Jackson Immunoresearch Labs, West Grove, PA) were diluted 1:200. Terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL) was done with a kit (Roche, Indianapolis, IN) [6] . Fluorescence photographs were taken under Olympus BX51 microscope digital camera (Olympus America, Center Valley, PA) and merged by means of Magna Fire software (Systat Co., San Jose, CA) [6] .
T cells were identified as positive for Pan T Cell marker and detected by immunofluorescence with the antibody raised against WAG/Rij spleen cells of rat origin. Absolute numbers were counted in a blinded fashion in the three predetermined peri-infarct regions of the ipsilateral hemisphere at the bregma (0) level then averaged and expressed per square millimeters, as described [5] . Seven nonirradiated and six irradiated rats per group were used to arrive at means with standard deviations. The identification of microglial cells was done with antibody against Iba1 and same as the above mathematical approach was applied to analyze microglial counts. Spleen cell counts were done in three marginal zone areas in the immediate vicinity of the white pulp of the spleen and expressed in square millimeter units.
Statistical Analysis
Means±standard deviation were calculated for all relevant parameters. One-way analysis of variance (ANOVA) with Holm-Sidak correction was performed to test for statistical significance of differences between means. When appropriate, a nonparametric Kruskal-Wallis ANOVA with Dunn's test was employed. Mortality rates were analyzed with a chi-square test. Correlation analysis was done with Pearson bivariate correlation test. A type I error at the p<0.05 level was considered statistically significant. The result calculations indicated a sufficient number of animals and/or sample counts were used for all but two variables to achieve power close to 0.80 (0.7-0.8). SigmaStat and SigmaPlot 12 software were used for statistical analysis (Systat Software Inc., Chicago, IL).
Results
Quantitative Blood Cell Count
Prior to surgery, white blood cell counts were equivalent in rats assigned to no irradiation ischemic group and irradiation groups although total WBC and lymphocyte numbers in the ischemic groups at 0 h were lower than in the sham group (Fig. 1) . However, at 24 h, only after splenic irradiation the lymphocyte and WBC counts were significantly reduced compared to sham or nonirradiated MCAO (Fig. 1b) . Lymphocyte and monocyte counts (Fig. 1c) tended to equalize in nonirradiated and irradiated groups at 48 h. Granulocyte counts showed an increasing trend in nonirradiated rats while plateaued in the irradiated group (Fig. 1d) . We observed a seemingly apparent correlation between spleen weight and lymphocyte blood cells counts at 48 h after surgery, which, however, did not reach statistical significance (p00.06, n03).
Infarction Volume, Neurological Scores, Body Weight and Mortality
Brain tissues unstained with TTC, consistent with infarction 48 h after ischemia, occupy smaller areas in rats with spleen irradiation compared to nonirradiated ( Fig. 2(ai) ). The volumetric analysis (Fig. 2(aii) ) demonstrates that splenic irradiation at 3 h after MCAO significantly reduced lesion volume measured at 48 h after ischemia (p00.026).
Representative photographs of Nissl stained brain sections in nonirradiated controls and in the irradiated group are shown in Fig. 2(bi) . Reduced extent of infarcted tissue can be seen in rats with spleens irradiated at 4 h (right panels). Irradiation at 4 h significantly reduced ischemic lesion volume (by 50.83 %) (Fig. 2(bii) ). Ischemic volume reduction was insignificant when splenic irradiation was delayed till 6 or 8 h (12.07 and 18.38 %, respectively). Irradiation carried out at 3 h after ischemia onset (experiment 1) resulted in a significant amelioration of neuroscores (13.33±1.16 vs.7.67±1.53; p00.007). However, in the experiment 2, splenic irradiation did not improve neurological scores (Fig. 2(c) ) or body weight loss ( Fig. 2(d) ) significantly. Seven-day mortality in nonirradiated MCAO rats was 12.5 %; in the 4-h irradiation group, 14.29 %; and in 6-and 8-h irradiation groups (sham-operated, 0 %), 25 %, without significant intergroup differences.
Reduced Spleen Size and Induction of Apoptosis after Irradiation
Forty eight hours after MCAO, the mean spleen weight in the nonirradiated MCAO group was 532.33±42.71 mg vs. 343.67±27.76 mg in rats irradiated 3 h after ischemia (35.44 % reduction, p00.003). The mean spleen weight was 944.75±116.45 mg in the sham surgery group and 660.0±96.18 mg in the no irradiation MCAO group on day 7 (Fig. 3a) . The spleen weight was 416.50±109.99 mg (38.24 % reduction compared to nonirradiated) when irradiation was done at 4 h after ischemia; 460.50±102.92 mg (−30.37 %) with 6-h delay, and 446.83 ± 106.89 mg (−35.16 %) after irradiation with 8-h delay, as compared to nonirradiated group (p<0.05 vs. control; Fig. 3b) .
Only scarcely distributed apoptotic cells were present in the spleen at 7 days after sham surgery (Fig. 3(ci, inset) ) or MCAO alone (Fig. 3(ci) ). Seven days after ischemia with irradiation at 4 h, many apoptotic cells were seen (Fig. 3(cii) ) and the double staining revealed TUNELpositive T cells (Fig. 3(cv) ). Few apoptotic cells were present in spleens of animals irradiated at 6 and 8 h after ischemia (Fig. 3(ciii and civ) ), which may suggest earlier deployment of spleen cells. In spleen areas adjacent to white pulp, the number of apoptotic cells increased significantly only in the 4-h group, by 445.86 %, as compared to nonirradiated group (p<0.05; Fig. 3d ). There was also a significant inverse correlation between spleen weight and number of apoptotic cells within spleens on day 7 (r0−0.491; p<0.01).
Suppression of Brain Inflammation in Rats Irradiated at 4 h
The first column of histological panels in Fig. 4a shows a reduction in brain-invading T cells in the 4-h irradiation group compared to the nonirradiated group and groups with irradiation at 6 and 8 h. Reductions in Iba1 and TUNELpositive cells (columns 2 and 3, respectively) were also seen in the 4-h irradiation group. The majority of apoptotic cells displayed neuronal marker NeuN (Fig. 4b) . In the 4-h irradiation group, the reduction in T cell numbers was by 78.23 % compared to the control group, while it was reduced by 35.07 and 46.48 % in the 6-and 8-h irradiation groups, respectively (Fig. 4c) . Notably, in all ischemic groups, there was a significant positive correlativity between spleen weight and invading lymphocyte numbers in the brain (correlation coefficient r00.618; p<0.01). The Iba1+ cell count was significantly reduced (by 54.73 %) in the 4-h group but not in other irradiation groups. The number of TUNEL + cells in the 4-h irradiation group was reduced to 15.73 % of that in the nonirradiated group (p< 0.05 ANOVA), while insignificant reductions, to 77.85 and 66.55 %, were also detected in the 6-and 8-h irradiation groups, respectively.
Microstructure of Visceral Organs
Lung tissue samples were collected 7 days after ischemia and stained with hematoxylin and eosin (H&E). Microscopic observations revealed no detectable thickening of alveolar Fig. 1 Peripheral blood leukocyte counts in rats with intact spleens or irradiated 3 h after ischemia. a There was a tendency towards reduced total white blood counts after irradiation as compared to nonirradiated ischemia group. b With splenic irradiation, lymphocyte levels were significantly reduced at 24 h after ischemia. c The reduction in the monocyte counts occurred after irradiation with respect to sham but without significant differences between ischemic groups, irradiated or not. d Granulocyte levels did not change significantly (asterisk p<0.05 vs. nonirradiated; number sign p< 0.05 vs. sham, ANOVA) walls and granulocyte infiltrates that would be consistent with increased microbial load as a consequence of splenic irradiation [7] . No structural differences were seen between lung samples obtained from the nonirradiated ischemia group (Fig. 5(ai) ) and from 4-h radiation group (Fig. 5(aii) ).
Examination of H&E-stained histological preparations revealed no signs of radiation injury to the abdominal organs at 7 days after splenic irradiation. The kidneys showed wellpreserved glomeruli and tubules (Fig. 5(bi and bii) ). Similarly, the lobuli and central vein of the liver showed normal morphology regardless if irradiated or not (Fig. 5(ci and cii) ). The histological preparations of the small intestine (known to be sensitive to acute radiation effects) were negative for the signs of radiation injury (e.g., flattening of the intestinal villi) (Fig. 5(dii) ).Similarly, well-preserved morphology of visceral organs was found in the groups of rats irradiated at 6 and 8 h after ischemia (data not shown).
Discussion
Irradiation of the spleen with 8 Gy of Cobalt-60 gamma rays resulted in spleen size reduction and death of spleen cells via apoptosis. To our knowledge, this is the first demonstration that postischemic ablation of the spleen by gamma irradiation reduced the volume of cerebral infarction. Moreover, statistical analysis confirmed that spleen weight and number of lymphocytes invading the ischemic brain were correlated with each other. This suggests that smaller spleens go along with fewer infiltrating cells and further corroborates the benefit of splenic irradiation for brain protection against neuroinflammation. Negative correlation between spleen weights and number of apoptotic spleen cells may then indicate that splenic irradiation eliminates spleen immunocytes through apoptosis. Finally, our observation that lowered lymphocyte blood levels tended to accompany the reduction in irradiated spleen weight might suggest that targeting spleen with radiation compromises its ability of releasing immunocytes in response to ischemic brain insult. Concordantly, at the ischemic border numbers of infiltrating lymphocytes, microglia, and apoptotic cells were reduced by splenic irradiation done 4 h after the onset of ischemia. The therapeutic window for splenic irradiation seems to end somewhere between 3 and 4 h after ischemic onset, considering that there was no functional improvement for irradiation at 4, 6, or 8 h after ischemia. The relatively short therapeutic window for splenic irradiation may appear surprising given that spleen immunocytes can enter the brain within hours and days after injury. Such result, however, may only indicate that splenic irradiation needs to target early deployment of these cells to provide neuroprotective effect.
Our results from irradiation at 4 h may suggest that when protective treatment does not reduce brain lesion below certain critical volume, the functional improvement does not occur. Earlier authors reported that favorable neurological outcomes cannot be anticipated if more than 80 cc of the human brain is infarcted [8] .
The neuroprotective effect of splenic irradiation on day 7 was associated with decreased apoptotic cell counts in the brain. Significant portion of TUNEL-positive cells correlated with neuronal marker NeuN. However, there were quite numerous nonneuronal TUNEL-positive cells as well. We want to point out that astrocytes might account for nonneuronal cells exhibiting TUNEL. The astrocytes have all the components needed to execute intrinsic and extrinsic pathways of apoptotic cell death [9] . Studies have shown marked increases in the number of astrocytes with DNA damage 7 days after focal cerebral ischemia [10] . Although further studies are warranted, it cannot be ruled out at this point that astrocytic apoptosis was present on day 7 after fulminate ischemic brain insult while splenic irradiation worked to the rescue of astrocytes in this setting.
The results of experiment 1 indicate that the acute brain protection, demonstrated by a reduced infarction size and improved neuroscores at 48 h, may also involve reduced blood lymphocyte numbers after irradiation. The initially observed difference in WBC and lymphocyte numbers between ischemic groups at 0 h and the sham group appears accidental and stems from physiological variations. The reported levels of WBC in normal male SD rats were 12.97±2.4×10 9 /L, and the range was rather broad, as it spanned from 8.1 to 21.5× 109/L, while lymphocyte percentage ranged from 37.4 to 91.9 % [11] . Later time point measurements confirmed no effect of sham surgery on the level of WBC and lymphocytes, while there was a marked decrease in those levels in the irradiated group, especially lymphocyte numbers (1.33±0.25×10 3 cells/mm 3 at 24 h after irradiation) which dropped below the normal range.
Lymphocytes, accounting for the majority of cells released by the spleen, have been implicated in the development of neuroinflammation, thrombosis, and neurological impairment in ischemic stroke [12] . Studies have shown that activated lymphocytes, which excessively produce inflammatory cytokines, can enter the brain, and adhere to, and kill neurons [13, 14] . The role of cytokines in apoptosis has been well established in the literatures [15] . Cytokines released by lymphoid cells can also cause neurotoxicity indirectly, via reactive oxygen species and excess of nitric oxide released from cytokine-activated glial cells [16] . Consequently, in T and B cell-deficient mice displaying reduced cytokine levels, total infarct volumes were significantly reduced at 22 h after 90 min MCAO [17] .
Splenic irradiation is highly effective in reducing spleen size in patients with lymphoepithelial and hemopoietic diseases associated with splenomegaly [18] . Spleen-derived immunologic cells are known to be very sensitive to irradiation and undergo apoptosis after relatively low doses of a few Gy [19] . Megavoltage radiation can easily penetrate lymphoid organs and provide almost immediate destruction of targeted cells. Thus, splenic irradiation is a simple and well-tolerated procedure and could be performed on stroke patients.
In contrast, surgical splenectomy is an invasive procedure carrying the risk of hemorrhage and splenosis [20] . Especially in the elderly, in whom the surgery itself can precipitate stroke-like complications, surgical splenectomy does not seem to make a good treatment option for stroke [21] .
It has been reported that after irradiation with doses below 10 Gy, splenic function can be regained by repopulation with cells from other lymphoid tissues within a matter of weeks. Conversely, doses larger than 10 Gy may induce stromal changes such as fibrosis, which may prevent complete restoration of splenic function [22] . The relatively short-time line of our study did not allow for the evaluation of long-term radiation effects in the spleen after a single dose of 8 Gy. To this end, further study is needed in order to examine the spleen recovery and long-term neurological outcomes.
It has been postulated that immunodepression occurring after stroke can compromise patients' outcomes [7] . In the present study, we did not find any histological signs of lung injury that could point towards increased microbial load following splenic irradiation. The plausible explanation is that the other lymphoid organs could compensate for immune functions of the spleen.
In addition, we did not observe any signs of radiation injury in the abdominal organs. This finding is consistent with the notion that a dose of 8 Gy in the spleen, with lower doses in downstream organs, was below the threshold for an acute radiation syndrome.
Conclusions
Splenic irradiation done up to 4 h after focal brain ischemia provides histological protection associated with widespread apoptotic cell death in the spleen and reduces brain infiltration by immunologic cells. This sizable neuroprotection was not accompanied by side effects from immune system or acute radiation syndrome. Splenic irradiation for cerebral ischemia, if further substantiated in the long-term outcome studies, may carry a promise for the clinical management of ischemic stroke.
